Items where Author is "Ruegg, M. A."

2015

Martin, S. K. and Fitter, S. and Dutta, A. K. and Matthews, M. P. and Walkley, C. R. and Hall, M. N. and Ruegg, M. A. and Gronthos, S. and Zannettino, A. C. W.. (2015) The differential roles of mTORC1 and mTORC2 in mesenchymal stem cell differentiation. Stem cells, Vol. 33, H. 4. pp. 1359-1365.

2014

Grahammer, F. and Haenisch, N. and Steinhardt, F. and Sander, L. and Roerden, M. and Arnold, F. and Cordts, T. and Wanner, N. and Reichardt, W. and Kerjaschki, D. and Ruegg, M. A. and Hall, M. N. and Moulin, P. and Busch, H. and Boerries, M. and Walz, G. and Artunc, F. and Huber, T. B.. (2014) mTORC1 maintains renal tubular homeostasis and is essential in response to ischemic stress. Proceedings of the National Academy of Sciences of the United States of America, 111 (27). E2817-E2826.

2013

Castets, P. and Lin, S. and Rion, N. and Di Fulvio, S. and Romanino, K. and Guridi, M. and Frank, S. and Tintignac, L. A. and Sinnreich, M. and Ruegg, M. A.. (2013) Sustained activation of mTORC1 in skeletal muscle inhibits constitutive and starvation-induced autophagy and causes a severe, late-onset myopathy. Cell metabolism, Vol. 17, H. 5. pp. 731-744.

2011

Shende, P. and Plaisance, I. and Morandi, C. and Pellieux, C. and Berthonneche, C. and Zorzato, F. and Krishnan, J. and Lerch, R. and Hall, M. N. and Ruegg, M. A. and Pedrazzini, T. and Brink, M.. (2011) Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice. Circulation, 123 (10). pp. 1073-1082.

Punga, A. R. and Maj, M. and Lin, S. and Meinen, S. and Ruegg, M. A.. (2011) MuSK levels differ between adult skeletal muscles and influence postsynaptic plasticity. The European journal of neuroscience, Vol. 33, H. 5. pp. 890-898.

Punga, A. R. and Lin, S. and Oliveri, F. and Meinen, S. and Ruegg, M. A.. (2011) Muscle-selective synaptic disassembly and reorganization in MuSK antibody positive MG mice. Experimental Neurology, 230 (2). pp. 207-217.

Godel, M. and Hartleben, B. and Herbach, N. and Liu, S. and Zschiedrich, S. and Lu, S. and Debreczeni-Mor, A. and Lindenmeyer, M. T. and Rastaldi, M. -P. and Hartleben, G. and Wiech, T. and Fornoni, A. and Nelson, R. G. and Kretzler, M. and Wanke, R. and Pavenstadt, H. and Kerjaschki, D. and Cohen, C. D. and Hall, M. N. and Ruegg, M. A. and Inoki, K. and Walz, G. and Huber, T. B.. (2011) Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. Journal of Clinical Investigation, 121 (6). pp. 2197-2209.

Inoki, K. and Mori, H. and Wang, J. and Suzuki, T. and Hong, S. and Yoshida, S. and Blattner, S. M. and Ikenoue, T. and Ruegg, M. A. and Hall, M. N. and Kwiatkowski, D. J. and Rastaldi, M. P. and Huber, T. B. and Kretzler, M. and Holzman, L. B. and Wiggins, R. C. and Guan, K. -L.. (2011) mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. Journal of Clinical Investigation, 121 (6). pp. 2181-2196.

2009

Huze, C. and Bauche, S. and Richard, P. and Chevessier, F. and Goillot, E. and Gaudon, K. and Ben Ammar, A. and Chaboud, A. and Grosjean, I. and Lecuyer, H. -A. and Bernard, V. and Rouche, A. and Alexandri, N. and Kuntzer, T. and Fardeau, M. and Fournier, E. and Brancaccio, A. and Ruegg, M. A. and Koenig, J. and Eymard, B. and Schaeffer, L. and Hantai, D.. (2009) Identification of an agrin mutation that causes congenital myasthenia and affects synapse function. American Journal of Human Genetics, 85 (2). pp. 155-167.

Erb, M. and Meinen, S. and Barzaghi, P. and Sumanovski, L. T. and Courdier-Fruh, I. and Ruegg, M. A. and Meier, T.. (2009) Omigapil ameliorates the pathology of muscle dystrophy caused by laminin-α2 deficiency. Journal of pharmacology and experimental therapeutics, 331 (3). pp. 787-795.

Patursky-Polischuk, I. and Stolovich-Rain, M. and Hausner-Hanochi, M. and Kasir, J. and Cybulski, N. and Avruch, J. and Ruegg, M. A. and Hall, M. N. and Meyuhas, O.. (2009) The TSC-mTOR pathway mediates translational activation of TOP mRNAs by insulin largely in a raptor- or rictor-independent manner. Molecular and cellular biology, Vol. 29, H. 3. pp. 640-649.

Cybulski, N. and Polak, P. and Auwerx, J. and Ruegg, M. A. and Hall, M. N.. (2009) mTOR complex 2 in adipose tissue negatively controls whole-body growth. Proceedings of the National Academy of Sciences of the United States of America, 106 (24). pp. 9902-9907.

2008

Polak, P. and Cybulski, N. and Feige, J. N. and Auwerx, J. and Ruegg, M. A. and Hall, M. N.. (2008) Adipose-Specific Knockout of raptor Results in Lean Mice with Enhanced Mitochondrial Respiration. Cell Metabolism, Vol. 8, H. 5. pp. 399-410.

Lin, S. and Maj, M. and Bezakova, G. and Magyar, J. P. and Brenner, H. R. and Ruegg, M. A.. (2008) Muscle-wide secretion of a miniaturized form of neural agrin rescues focal neuromuscular innervation in agrin mutant mice. Proceedings of the National Academy of Sciences of the United States of America, 105 (32). pp. 11406-11411.

Reiterer, V. and Maier, S. and Sitte, H. H. and Kriz, A. and Ruegg, M. A. and Hauri, H. P. and Freissmuth, M. and Farhan, H.. (2008) Sec24- and ARFGAP1-dependent trafficking of GABA transporter-1 is a prerequisite for correct axonal targeting. Journal of Neuroscience, 28 (47). pp. 12453-12464.

Bentzinger, C. F. and Romanino, K. and Cloetta, D. and Lin, S. and Mascarenhas, J. B. and Oliveri, F. and Xia, J. and Casanova, E. and Costa, C. F. and Brink, M. and Zorzato, F. and Hall, M. N. and Ruegg, M. A.. (2008) Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. Cell Metabolism, Vol. 8, H. 5. pp. 411-424.

Lin, S. and Landmann, L. and Ruegg, M. A. and Brenner, H. R.. (2008) The role of nerve- versus muscle-derived factors in mammalian neuromuscular junction formation. Journal of neuroscience, Vol. 28, H. 13. pp. 3333-3340.

2007

Hausser, H. -J. and Ruegg, M. A. and Brenner, R. E. and Ksiazek, I.. (2007) Agrin is highly expressed by chondrocytes and is required for normal growth. Histochemistry and Cell Biology, 127 (4). pp. 363-374.

Meinen, S. and Barzaghi, P. and Lin, S. and Lochmuller, H. and Ruegg, M. A.. (2007) Linker molecules between laminins and dystroglycan ameliorate laminin-alpha2-deficient muscular dystrophy at all disease stages. The Journal of cell biology, Vol. 176, H. 7. pp. 979-993.

Camilleri, A. A. and Willmann, R. and Sadasivam, G. and Lin, S. and Ruegg, M. A. and Gesemann, M. and Fuhrer, C.. (2007) Tyrosine phosphatases such as SHP-2 act in a balance with Src-family kinases in stabilization of postsynaptic clusters of acetylcholine receptors. BMC Neuroscience, 8 (46). pp. 1-16.

2006

Scotton, P. and Bleckmann, D. and Stebler, M. and Sciandra, F. and Brancaccio, A. and Meier, T. and Stetefeld, J. and Ruegg, M. A.. (2006) Activation of muscle-specific receptor tyrosine kinase and binding to dystroglycan are regulated by alternative mRNA splicing of agrin. Journal of Biological Chemistry, 281 (48). pp. 36835-36845.

Annies, M. and Bittcher, G. and Ramseger, R. and Loschinger, J. and Woll, S. and Porten, E. and Abraham, C. and Ruegg, M. A. and Kroger, S.. (2006) Clustering transmembrane-agrin induces filopodia-like processes on axons and dendrites. Molecular and cellular neuroscience, Vol. 31, H. 3. pp. 515-524.

Ruegg, M. A.. (2006) Commonalities and differences in muscular dystrophies : mechanisms and molecules involved in merosin-deficient congenital muscular dystrophy. In: Molecular mechanisms of muscular dystrophies. Georgetown, Tex., pp. 74-81.

Meinen, S. and Ruegg, M. A.. (2006) Congenital muscular dystrophy: mini-agrin delivers in mice. Gene Therapy, Vol. 13, H. 11. pp. 869-870.

Possekel, S. and Meier, T. and Ruegg, M. A.. (2006) Peripheral signaling pathways involved in muscle loss. In: Pharmacotherapy of Cachexia. Boca Raton, FL, USA, pp. 543-564.

Jokic, N. and Gonzalez de Aguilar, J. -L. and Dimou, L. and Lin, S. and Fergani, A. and Ruegg, M. A. and Schwab, M. E. and Dupuis, L. and Loeffler, J. -P.. (2006) The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model. EMBO reports, Vol. 7, H. 11. pp. 1162-1167.

2005

Smirnov, S. P. and Barzaghi, P. and McKee, K. K. and Ruegg, M. A. and Yurchenco, P. D.. (2005) Conjugation of LG domains of agrins and perlecan to polymerizing laminin-2 promotes acetylcholine receptor clustering. Journal of Biological Chemistry, 280 (50). pp. 41449-41457.

Ruegg, M. A.. (2005) Organization of synaptic myonuclei by Syne proteins and their role during the formation of the nerve-muscle synapse. Proceedings of the National Academy of Sciences of the United States of America, 102 (16). pp. 5643-5644.

Bentzinger, C. F. and Barzaghi, P. and Lin, S. and Ruegg, M. A.. (2005) Overexpression of mini-agrin in skeletal muscle increases muscle integrity and regenerative capacity in laminin-alpha2-deficient mice. FASEB Journal, 19 (8). pp. 934-942.

Sadasivam, G. and Willmann, R. and Lin, S. and Erb-Vogtli, S. and Kong, X. C. and Ruegg, M. A. and Fuhrer, C.. (2005) Src-family kinases stabilize the neuromuscular synapse in vivo via protein interactions, phosphorylation, and cytoskeletal linkage of acetylcholine receptors. Journal of Neuroscience, 25 (45). pp. 10479-10493.

Stetefeld, J. and Ruegg, M. A.. (2005) Structural and functional diversity generated by alternative mRNA splicing. Trends in biochemical sciences, Vol. 30, H. 9. pp. 515-521.

Mascarenhas, J. B. and Ruegg, M. A. and Sasaki, T. and Eble, J. A. and Engel, J. and Stetefeld, J.. (2005) Structure and laminin-binding specificity of the NtA domain expressed in eukaryotic cells. Matrix Biology, Vol. 23, H. 8. pp. 507-513.

Madhavan, R. and Zhao, X. T. and Ruegg, M. A. and Peng, H. B.. (2005) Tyrosine phosphatase regulation of MuSK-dependent acetylcholine receptor clustering. Molecular and cellular neuroscience, Vol. 28, H. 3. pp. 403-416.

2004

Ruegg, M. A. and McMahan, U. J.. (2004) Agrin. In: Encyclopedia of Neuroscience. Amsterdam.

Kong, X. C. and Barzaghi, P. and Ruegg, M. A.. (2004) Inhibition of synapse assembly in mammalian muscle in vivo by RNA interference. EMBO reports, Vol. 5, H. 2. pp. 183-188.

Jacinto, E. and Loewith, R. and Schmidt, A. and Lin, S. and Ruegg, M. A. and Hall, A. and Hall, M. N.. (2004) Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nature Cell Biology, Vol. 6, H. 11. pp. 1122-1128.

Stetefeld, J. and Alexandrescu, A. T. and Maciejewski, M. W. and Jenny, M. and Rathgeb-Szabo, K. and Schulthess, T. and Landwehr, R. and Frank, S. and Ruegg, M. A. and Kammerer, R. A.. (2004) Modulation of agrin function by alternative splicing and Ca2+ binding. Structure: with folding and design, Vol. 12, H. 3. pp. 503-515.

2003

Eusebio, A. and Oliveri, F. and Barzaghi, P. and Ruegg, M. A.. (2003) Expression of mouse agrin in normal, denervated and dystrophic muscle. Neuromuscular Disorders, Vol. 13, H. 5. pp. 408-415.

Bartoccioni, E. and Marino, M. and Evoli, A. and Ruegg, M. A. and Scuderi, F. and Provenzano, C.. (2003) Identification of disease-specific autoantibodies in seronegative myasthenia gravis. Annals of the New York Academy of Sciences, 998. pp. 356-358.

Guo, L. T. and Zhang, X. U. and Kuang, W. and Xu, H. and Liu, L. A. and Vilquin, J. -T. and Miyagoe-Suzuki, Y. and Takeda, S. and Ruegg, M. A. and Wewer, U. M. and Engvall, E.. (2003) Laminin alpha2 deficiency and muscular dystrophy : genotype-phenotype correlation in mutant mice. Neuromuscular Disorders, Vol. 13, H. 3. pp. 207-215.

Mascarenhas, J. B. and Ruegg, M. A. and Winzen, U. and Halfter, W. and Engel, J. and Stetefeld, J.. (2003) Mapping of the laminin-binding site of the N-terminal agrin domain (NtA). The EMBO Journal, 22 (3). pp. 529-536.

Bezakova, G. and Ruegg, M. A.. (2003) New insights into the roles of agrin. Nature reviews. Molecular cell biology, Vol. 4, H. 4. pp. 295-308.

2002

Bixby, J. L. and Baerwald-De la Torre, K. and Wang, C. and Rathjen, F. G. and Ruegg, M. A.. (2002) A neuronal inhibitory domain in the N-terminal half of agrin. Journal of Neurobiology, 50 (2). pp. 164-179.

Abicht, A. and Stucka, R. and Schmidt, C. and Briguet, A. and Hopfner, S. and Song, I. -H. and Pongratz, D. and Muller-Felber, W. and Ruegg, M. A. and Lochmuller, H.. (2002) A newly identified chromosomal microdeletion and an N-box mutation of the AChR epsilon gene cause a congenital myasthenic syndrome. Brain, 125 (5). pp. 1005-1013.

Pun, S. and Sigrist, M. and Santos, A. F. and Ruegg, M. A. and Sanes, J. R. and Jessell, T. M. and Arber, S. and Caroni, P.. (2002) An intrinsic distinction in neuromuscular junction assembly and maintenance in different skeletal muscles. Neuron, Vol. 34, H. 3. pp. 357-370.

2001

Alexandrescu, A. T. and Maciejewski, M. W. and Ruegg, M. A. and Engel, J. and Kammerer, R. A.. (2001) 1H, 13C and 15N backbone assignments for the C-terminal globular domain of agrin. Journal of Biomolecular NMR, 20 (3). pp. 295-296.

Moll, J. and Barzaghi, P. and Lin, S. and Bezakova, G. and Lochmuller, H. and Engvall, E. and Muller, U. and Ruegg, M. A.. (2001) An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy. Nature, 413 (6853). pp. 302-307.

Neumann, F. R. and Bittcher, G. and Annies, M. and Schumacher, B. and Kroger, S. and Ruegg, M. A.. (2001) An alternative amino-terminus expressed in the central nervous system converts agrin to a type II transmembrane protein. Molecular and cellular neuroscience, Vol. 17, H. 1. pp. 208-225.

Ruegg, M. A.. (2001) Molecules involved in the formation of synaptic connections in muscle and brain. Matrix Biology, Vol. 20, H. 1. pp. 3-12.

Stetefeld, J. and Jenny, M. and Schulthess, T. and Landwehr, R. and Schumacher, B. and Frank, S. and Ruegg, M. A. and Engel, J. and Kammerer, R. A.. (2001) The laminin-binding domain of agrin is structurally related to N-TIMP-1. Nature Structural biology, Vol. 8, H. 8. pp. 705-709.

2000

Sommer, B. and Barbieri, S. and Hofele, K. and Wiederhold, K. and Probst, A. and Mistl, C. and Danner, S. and Kauffmann, S. and Spooren, W. and Tolnay, M. and Bilbe, G. and Kafmann, S. and Caromi, P. and Ruegg, M. A.. (2000) Mouse models of alpha-synucleinopathy and Lewy pathology. Experimental gerontology, Vol. 35, no. 9-10. pp. 1389-1403.

van der Putten, H. and Wiederhold, K. H. and Probst, A. and Barbieri, S. and Mistl, C. and Danner, S. and Kauffmann, S. and Hofele, K. and Spooren, W. P. and Ruegg, M. A. and Lin, S. and Caroni, P. and Sommer, B. and Tolnay, M. and Bilbe, G.. (2000) Neuropathology in mice expressing human alpha-synuclein. Journal of Neuroscience, 20 (16). pp. 6021-6029.

Briguet, A. and Ruegg, M. A.. (2000) The Ets transcription factor GABP is required for postsynaptic differentiation in vivo. Journal of neuroscience, Vol. 20, H. 16. pp. 5989-5996.

Meier, T. and Ruegg, M. A.. (2000) The Role of Dystroglycan and Its Ligands in Physiology and Disease. News in physiological sciences, Vol. 15. pp. 255-259.

1999

Kammerer, R. A. and Schulthess, T. and Landwehr, R. and Schumacher, B. and Lustig, A. and Yurchenco, P. D. and Ruegg, M. A. and Engel, J. and Denzer, A. J.. (1999) Interaction of agrin with laminin requires a coiled-coil conformation of the agrin-binding site within the laminin gamma1 chain. The EMBO Journal, 18 (23). pp. 6762-6770.

1998

Meier, T. and Marangi, P. A. and Moll, J. and Hauser, D. M. and Brenner, H. R. and Ruegg, M. A.. (1998) A minigene of neural agrin encoding the laminin-binding and acetylcholine receptor-aggregating domains is sufficient to induce postsynaptic differentiation in muscle fibres. The European journal of neuroscience, Vol. 10, H. 10. pp. 3141-3152.

Gesemann, M. and Brancaccio, A. and Schumacher, B. and Ruegg, M. A.. (1998) Agrin is a high-affinity binding protein of dystroglycan in non-muscle tissue. Journal of Biological Chemistry, 273 (1). pp. 600-605.

Groffen, A. J. and Ruegg, M. A. and Dijkman, H. and van de Velden, T. J. and Buskens, C. A. and van den Born, J. and Assmann, K. J. and Monnens, L. A. and Veerkamp, J. H. and van den Heuvel, L. P.. (1998) Agrin is a major heparan sulfate proteoglycan in the human glomerular basement membrane. Journal of Histochemistry and Cytochemistry, 46 (1). pp. 19-27.

Ruegg, M. A. and Bixby, J. L.. (1998) Agrin orchestrates synaptic differentiation at the vertebrate neuromuscular junction. Trends in Neurosciences, 21 (1). pp. 22-27.

Nawrotzki, R. and Loh, N. Y. and Ruegg, M. A. and Davies, K. E. and Blake, D. J.. (1998) Characterisation of alpha-dystrobrevin in muscle. Journal of Cell Science, 111 (17). pp. 2595-2605.

Sieb, J. P. and Dorfler, P. and Tzartos, S. and Wewer, U. M. and Ruegg, M. A. and Meyer, D. and Baumann, I. and Lindemuth, R. and Jakschik, J. and Ries, F.. (1998) Congenital myasthenic syndromes in two kinships with end-plate acetylcholine receptor and utrophin deficiency. Neurology, 50 (1). pp. 54-61.

Denzer, A. J. and Schulthess, T. and Fauser, C. and Schumacher, B. and Kammerer, R. A. and Engel, J. and Ruegg, M. A.. (1998) Electron microscopic structure of agrin and mapping of its binding site in laminin-1. The EMBO Journal, 17 (2). pp. 335-343.

Meier, T. and Ruegg, M. A. and Wallace, B. G.. (1998) Muscle-specific agrin isoforms reduce phosphorylation of AChR gamma and delta subunits in cultured muscle cells. Molecular and cellular neuroscience, Vol. 11, H. 4. pp. 206-216.

1997

Denzer, A. J. and Brandenberger, R. and Gesemann, M. and Chiquet, M. and Ruegg, M. A.. (1997) Agrin binds to the nerve-muscle basal lamina via laminin. The Journal of cell biology, Vol. 137, H. 3. pp. 671-683.

Campagna, J. A. and Ruegg, M. A. and Bixby, J. L.. (1997) Evidence that agrin directly influences presynaptic differentiation at neuromuscular junctions in vitro. The European journal of neuroscience, Vol. 9, H. 11. pp. 2269-2283.

Meier, T. and Hauser, D. M. and Chiquet, M. and Landmann, L. and Ruegg, M. A. and Brenner, H. R.. (1997) Neural agrin induces ectopic postsynaptic specializations in innervated muscle fibers. Journal of neuroscience, Vol. 17, H. 17. pp. 6534-6544.

Denzer, A. J. and Hauser, D. M. and Gesemann, M. and Ruegg, M. A.. (1997) Synaptic differentiation : the role of agrin in the formation and maintenance of the neuromuscular junction. Cell and Tissue Research, 290 (2). pp. 357-365.

1996

Meier, T. and Gesemann, M. and Cavalli, V. and Ruegg, M. A. and Wallace, B. G.. (1996) AChR phosphorylation and aggregation induced by an agrin fragment that lacks the binding domain for alpha-dystroglycan. The EMBO Journal, 15 (11). pp. 2625-2631.

Ruegg, M. A.. (1996) Agrin, laminin beta 2 (s-laminin) and ARIA : their role in neuromuscular development. Current Opinion in Neurobiology, Vol. 6, H. 1. pp. 97-103.

Gesemann, M. and Cavalli, V. and Denzer, A. J. and Brancaccio, A. and Schumacher, B. and Ruegg, M. A.. (1996) Alternative splicing of agrin alters its binding to heparin, dystroglycan, and the putative agrin receptor. Neuron, Vol. 16, H. 4. pp. 755-767.

Yamada, H. and Denzer, A. J. and Hori, H. and Tanaka, T. and Anderson, L. V. and Fujita, S. and Fukuta-Ohi, H. and Shimizu, T. and Ruegg, M. A. and Matsumura, K.. (1996) Dystroglycan is a dual receptor for agrin and laminin-2 in Schwann cell membrane. Journal of Biological Chemistry, 271 (38). pp. 23418-23423.

Jones, G. and Herczeg, A. and Ruegg, M. A. and Lichtsteiner, M. and Kroger, S. and Brenner, H. R.. (1996) Substrate-bound agrin induces expression of acetylcholine receptor epsilon-subunit gene in cultured mammalian muscle cells. Proceedings of the National Academy of Sciences of the United States of America, 93 (12). pp. 5985-5990.

1995

Gesemann, M. and Denzer, A. J. and Ruegg, M. A.. (1995) Acetylcholine receptor-aggregating activity of agrin isoforms and mapping of the active site. The Journal of cell biology, Vol. 128, H. 4. pp. 625-636.

Campagna, J. A. and Ruegg, M. A. and Bixby, J. L.. (1995) Agrin is a differentiation-inducing "stop signal" for motoneurons in vitro. Neuron, Vol. 15, H. 6. pp. 1365-1374.

Denzer, A. J. and Gesemann, M. and Schumacher, B. and Ruegg, M. A.. (1995) An amino-terminal extension is required for the secretion of chick agrin and its binding to extracellular matrix. The Journal of cell biology, Vol. 131, H. 6. pp. 1547-1560.

Brancaccio, A. and Ruegg, M. A. and Engel, J.. (1995) Cloning and sequencing of mouse skeletal muscle alpha-dystroglycan. Matrix biology, Vol. 14, H. 8. pp. 681-685.

1992

McMahan, U. J. and Horton, S. E. and Werle, M. J. and Honig, L. S. and Kroger, S. and Ruegg, M. A. and Escher, G.. (1992) Agrin isoforms and their role in synaptogenesis. Current opinion in cell biology, Vol. 4, H. 5. pp. 869-874.

Ruegg, M. A. and Tsim, K. W. and Horton, S. E. and Kroger, S. and Escher, G. and Gensch, E. M. and McMahan, U. J.. (1992) The agrin gene codes for a family of basal lamina proteins that differ in function and distribution. Neuron, Vol. 8, H. 4. pp. 691-699.

Tsim, K. W. and Ruegg, M. A. and Escher, G. and Kroger, S. and McMahan, U. J.. (1992) cDNA that encodes active agrin. Neuron, Vol. 8, H. 4. pp. 677-689.

1991

Stoeckli, E. T. and Kuhn, T. B. and Duc, C. O. and Ruegg, M. A. and Sonderegger, P.. (1991) The axonally secreted protein axonin-1 is a potent substratum for neurite growth. Journal of Cell Biology, 112 (3). pp. 449-455.

1989

Ruegg, M. A. and Stoeckli, E. T. and Lanz, R. B. and Streit, P. and Sonderegger, P.. (1989) A homologue of the axonally secreted protein axonin-1 is an integral membrane protein of nerve fiber tracts involved in neurite fasciculation. Journal of cell biology, 109, H. 5 (5). pp. 2363-2378.

Stoeckli, E. T. and Lemkin, P. F. and Kuhn, T. B. and Ruegg, M. A. and Heller, M. and Sonderegger, P.. (1989) Identification of proteins secreted from axons of embryonic dorsal-root-ganglia neurons. European Journal of Biochemistry, 180 (2). pp. 249-258.

Ruegg, M. A. and Stoeckli, E. T. and Kuhn, T. B. and Heller, M. and Zuellig, R. and Sonderegger, P.. (1989) Purification of axonin-1, a protein that is secreted from axons during neurogenesis. The EMBO Journal, 8 (1). pp. 55-63.